Our study supports a link between excessive m6A and tau pathology and shows that inhibiting the m6A writer METTL3 with small molecule STM2457 reduces tau deposition, mitigates neurodegeneration, and prevents cognitive decline in PS19 mice. The gene discussed is MAPT; the disease is Mental deterioration.